Inventor · disambiguated record
Shingo Maeta
Also filed as: MAETA SHINGO
6 granted patents·7 pending applications·9 citations·filing 2017–2024
77Inventor score
Top patents by PatentIndex Score
13 records- 0194US11795237B2Method for improving affinity of antibody for antigen and use thereofSYSMEX CORP·Filed 2021·Granted Oct 24, 2023·4 cites·12 claims
- 0293US12139552B2Method for improving affinity of antibody for antigen and use thereofSYSMEX CORP·Filed 2023·Granted Nov 12, 2024·1 cites·9 claims
- 0393US12122849B2Method for improving affinity of antibody for antigen and use thereofSYSMEX CORP·Filed 2023·Granted Oct 22, 2024·1 cites·12 claims
- 0493US12116419B2Method for improving affinity of antibody for antigen and use thereofSYSMEX CORP·Filed 2023·Granted Oct 15, 2024·1 cites·12 claims
- 0582US11267904B2Method for controlling affinity of antibody for antigen, antibody whose affinity for antigen has been altered, and its production methodSYSMEX CORP·Filed 2017·Granted Mar 8, 2022·2 cites·4 claims
- 0677US2022220191A1Method for improving affinity of antibody for antigen and use thereofSYSMEX CORP·Filed 2022·Application pending·0 cites
- 0777US2022230705A1Method for improving affinity of antibody for antigen and use thereofSYSMEX CORP·Filed 2022·Application pending·0 cites
- 0871US12304971B2Method for controlling affinity of antibody for antigen, antibody whose affinity for antigen has been altered, and its production methodSYSMEX CORP·Filed 2022·Granted May 20, 2025·0 cites·8 claims
- 0965US2025084180A1Nucleic acid molecule encoding car and vector comprising the same, immune cell including car and pharmaceutical composition comprising the cell, method for improving cytotoxic activity, and method for producing immune cell including carUNIV MIE·Filed 2024·Application pending·0 cites
- 1062US2023265210A1Method for improving affinity of antibody for antigen and use thereofSYSMEX CORP·Filed 2023·Application pending·0 cites
- 1161US2024360225A1METHOD FOR PRODUCING ANTI-EGFR ANTIBODY, METHOD FOR IMPROVING AFFINITY FOR Fc¿RIIIa, AND ANTI-EGFR ANTIBODYSYSMEX CORP·Filed 2024·Application pending·0 cites
- 1261US2023228866A1Method for improving affinity of antibody for antigen and use thereofSYSMEX CORP·Filed 2023·Application pending·0 cites
- 1358US2023091175A1Method for improving affinity of anti-cytokine antibody for antigen, method for producing anti-cytokine antibody, and anti-cytokine antibodySYSMEX CORP·Filed 2022·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →